How real-world evidence transforms the entire healthcare ecosystem
From drug development to value-based care, there is a huge opportunity to tap into real-world data (RWD) to improve patient outcomes.
IDMP as a business-driven initiative
Rather than view IDMP as just a regulatory compliance requirement, life sciences companies should embrace it as an opportunity to create a more robust, standardized data-driven environment.
Tackling the problem of antimicrobial resistance
Singapore General Hospital is working with DXC to use AI to automate the process of auditing antibiotic usage to ensure optimal use and reduce hospital stays, mortality and readmission rates.
Accelerating life sciences innovation
DXC’s digital technologies give life sciences organizations the tools they need to accelerate innovation and reduce time-to-market for new therapies, devices and medicines. DXC’s proven expertise helps customers improve business agility and operational efficiency.
- 250K global users
- 70K regulatory submissions with zero refusals by regulatory authorities
- 15K pharma products approved and managed
- 100% of U.S. Fortune 500 pharma companies are DXC customers
Manage activities across the entire RIM life cycle
Manage activities across the entire RIM life cycle
Our regulatory transformation solutions help life sciences companies achieve greater agility in drug discovery, development, manufacturing and market access.
Reduce time to market
Reduce time to market
Simplify the submission process, create efficiencies and shorten time-to-market for new therapies with our regulatory business automation software to manage the entire submission life cycle.
Accelerate innovation
Accelerate innovation
DXC brings together life sciences expertise, technical knowledge and real-world evidence to enable transformative innovation with a comprehensive suite of business process services.
Advance digital transformation
Advance digital transformation
DXC’s transformational digital solutions help customers to respond rapidly to regulatory and technology changes with minimal risk.
